Stocks expected to have increasing option volume: MRNA RGEN DHR TMO MRVI SKHY
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/22/2026
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Oil price dips to $100 on hopes of US-Iran diplomacy, partial recovery in Saudi exports
- Paramount, Warner Bros jump on report of settlement progress in merger fight
- Investors may be underpricing how far rate hikes could go, Deutsche says
- Pennsylvania measles cases near 800 as outbreak grows
- A timeline of Trump administration moves to weaken endangered species protections
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Nasdaq notches record-high close, AI optimism reignites and Treasury yields retreat
- SpaceX and Tesla’s AI linkup is getting deeper. Here’s what Morgan Stanley sees
Moderna (MRNA) PT Raised to $89 at Morgan Stanley
August 19, 2026 4:23 PM EDTMorgan Stanley analyst Terence Flynn raised the price target on Moderna (NASDAQ: MRNA) to $89.00 (from $39.00) while maintaining a Equalweight rating.
The analyst comments "We are Equal-weight Moderna. While we believe there is long-term upside for Moderna, we believe the significant valuation increase... More
